Cardinal Health, Inc. (CAH) trades at a trailing P/E of 30.6, forward P/E of 20.8. Trailing earnings yield is 3.27%, forward earnings yield 4.80%. PEG 0.35 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
Overall SharesGrow Score: 56/100 with 1/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | 17.9 | 0.93 | 3.89 | 0.21 | 2.01% |
| 2017 | 19.2 | -2.79 | 3.63 | 0.19 | 2.34% |
| 2018 | 59.7 | -0.75 | 2.52 | 0.11 | 3.80% |
| 2019 | 10.5 | 0.02 | 2.25 | 0.10 | 4.04% |
| 2020 | -4.1 | 0.01 | 8.55 | 0.10 | 3.72% |
| 2021 | 27.3 | -0.23 | 9.31 | 0.10 | 3.44% |
| 2022 | -15.5 | 0.06 | -20.57 | 0.08 | 3.83% |
| 2023 | 74.8 | -0.54 | -8.34 | 0.12 | 2.13% |
| 2024 | 28.1 | 0.16 | -7.45 | 0.11 | 2.08% |
| 2025 | 25.9 | 0.30 | -14.56 | 0.18 | 1.22% |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $4.32 | $121.55B | $1.43B | 1.2% |
| 2017 | $4.03 | $129.98B | $1.29B | 1% |
| 2018 | $0.81 | $136.81B | $256M | 0.2% |
| 2019 | $4.53 | $145.53B | $1.36B | 0.9% |
| 2020 | $-12.60 | $152.92B | $-3.69B | -2.4% |
| 2021 | $2.08 | $162.47B | $611M | 0.4% |
| 2022 | $-3.34 | $181.36B | $-932M | -0.5% |
| 2023 | $1.00 | $205.01B | $261M | 0.1% |
| 2024 | $3.45 | $226.83B | $852M | 0.4% |
| 2025 | $6.45 | $222.58B | $1.56B | 0.7% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $10.31 | $10.20 – $10.43 | $258.62B | $257.45B – $262.89B | 10 |
| 2027 | $11.60 | $10.07 – $11.95 | $281.9B | $272.56B – $290.73B | 10 |
| 2028 | $13.03 | $11.84 – $14.17 | $303.92B | $303.7B – $304.13B | 5 |
| 2029 | $14.88 | $14.48 – $15.40 | $334.38B | $327.46B – $343.39B | 1 |
| 2030 | $17.35 | $16.88 – $17.96 | $374.32B | $366.57B – $384.4B | 1 |
